SARS-CoV-2 challenge studies: ethics and risk minimisation

Journal of Medical Ethics 47 (12):e79-e79 (2021)
  Copy   BIBTEX

Abstract

COVID-19 poses an exceptional threat to global public health and well-being. Recognition of the need to develop effective vaccines at unprecedented speed has led to calls to accelerate research pathways ethically, including by conducting challenge studies ) with SARS-CoV-2. Such research is controversial, with concerns being raised about the social, legal, ethical and clinical implications of infecting healthy volunteers with SARS-CoV-2 for research purposes. Systematic risk evaluations are critical to inform assessments of the ethics of any proposed SARS-CoV-2 CHIs. Such evaluations will necessarily take place within a rapidly changing and at times contested epidemiological landscape, in which differing criteria for the ethical acceptability of research risks have been proposed. This paper critically reviews two such criteria and evaluates whether the use of effective treatment should be a necessary condition for the ethical acceptability of SARS-CoV-2 CHIs, and whether the choice of study sites should be influenced by COVID-19 incidence levels. The paper concludes that ethical evaluations of proposed SARS-CoV-2 CHIs should be informed by rigorous, consultative and holistic approaches to systematic risk assessment.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 74,310

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Challenge Studies of Human Volunteers: Ethical Issues.T. Hope - 2004 - Journal of Medical Ethics 30 (1):110-116.

Analytics

Added to PP
2020-09-26

Downloads
8 (#980,047)

6 months
1 (#415,900)

Historical graph of downloads
How can I increase my downloads?